The European Academy of Neurology (EAN) is proposing a new study on the topic of excessive daytime sleepiness and insomnia. Its initial idea was inspired by the European Brain Council (EBC)’s Value of Treatment projects.
In recent times, the importance of adequate sleep has become increasingly appreciated. Two well recognised syndromes include Insomnia (IN, prevalence in the general population: 10-20 %) and excessive daytime sleepiness (EDS, 5-15 %). Although the consequences of these conditions for quality of life have been acknowledged to some extent, an understanding of the economic impact that an adequate therapeutic management can have and research data coming from a patient-centred perspective is practically non-existent.
Consequently, this research intends not only to systematically assess the scientific literature on this topic but also to explore the socio-economic consequences of insomnia and daytime sleepiness, taking into consideration a patient-centred perspective. This study aims to assess the socio-economic and individual impact of daytime sleepiness and insomnia in individuals who attend the praxis of family general practitioners (GPs) and paediatricians in at least two different countries.
On 31 March, 2022 a cooperation agreement was officially finalised between EAN and its various neurological partner societies. Our sincere thanks to EPA, ESRS, EPNS, EFNA and Alzheimer Europe for officially joining this important scientific project!
Research Project Manager: Dr. Maria Lolich